C07D 213/74
Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
C07D213/74 (Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals) appears on 2,305 US grants and 2,283 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,305
- Published applications
- 2,283
- Assignees
- 1,111
- Inventors
- 7,926
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 23 | 0 |
| 1977 | 30 | 0 |
| 1978 | 18 | 0 |
| 1979 | 21 | 0 |
| 1980 | 21 | 0 |
| 1981 | 20 | 0 |
| 1982 | 19 | 0 |
| 1983 | 11 | 0 |
| 1984 | 24 | 0 |
| 1985 | 25 | 0 |
| 1986 | 25 | 0 |
| 1987 | 28 | 0 |
| 1988 | 22 | 0 |
| 1989 | 21 | 0 |
| 1990 | 32 | 0 |
| 1991 | 35 | 0 |
| 1992 | 37 | 0 |
| 1993 | 30 | 0 |
| 1994 | 28 | 0 |
| 1995 | 37 | 0 |
| 1996 | 26 | 0 |
| 1997 | 32 | 0 |
| 1998 | 28 | 0 |
| 1999 | 45 | 0 |
| 2000 | 38 | 0 |
| 2001 | 49 | 13 |
| 2002 | 65 | 75 |
| 2003 | 55 | 104 |
| 2004 | 55 | 131 |
| 2005 | 57 | 109 |
| 2006 | 77 | 110 |
| 2007 | 66 | 89 |
| 2008 | 58 | 93 |
| 2009 | 58 | 105 |
| 2010 | 71 | 114 |
| 2011 | 69 | 103 |
| 2012 | 50 | 97 |
| 2013 | 80 | 91 |
| 2014 | 97 | 130 |
| 2015 | 106 | 115 |
| 2016 | 79 | 98 |
| 2017 | 107 | 109 |
| 2018 | 72 | 80 |
| 2019 | 68 | 69 |
| 2020 | 65 | 72 |
| 2021 | 49 | 71 |
| 2022 | 39 | 67 |
| 2023 | 34 | 73 |
| 2024 | 29 | 78 |
| 2025 | 46 | 48 |
| 2026 | 28 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Reagent for mass spectrometry29 Sep 2026US 12,748,116 B2Roche Diagnostics Operations, Inc.
- Lipoxygenase inhibitors22 Sep 2026US 12,741,926 B2SRI International
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Inhibitors of Notch Signaling Pathway and Use Thereof in Treatment of Cancers1 Oct 2026US 2026/0297082 A1Cellestia Biotech AG
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Novel ionizable lipid and lipid nanoparticle composition using same17 Sep 2026US 2026/0272837 A1MediciBIO Co., Ltd
- Selective alpha-2c adrenergic receptor agonists and uses thereof17 Sep 2026US 2026/0272901 A1AlpheraBio LLC
- Antibacterial compounds17 Sep 2026US 2026/0274816 A1The Penn State Research Foundation
Most cited
By later US patents
- Intermediates for imidazo[4,5-c]pyridin-4-amines248US 5,446,153 AMinnesota Mining and Manufacturing Company · 1995
- Platinum complex and light emitting device154US 7,442,797 B2Takasago International Corporation · 2008
- Oxazolopyridine compounds, compositions and use148US 5,130,311 AAdir et Compagnie · 1992
- Imidazo[4,5-C]pyridin-4-amines147US 5,494,916 AMinnesota Mining and Manufacturing Company · 1996
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001